BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10679654)

  • 1. Paraganglioma of the urinary bladder: can biologic potential be predicted?
    Cheng L; Leibovich BC; Cheville JC; Ramnani DM; Sebo TJ; Neumann RM; Nascimento AG; Zincke H; Bostwick DG
    Cancer; 2000 Feb; 88(4):844-52. PubMed ID: 10679654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraganglioma of the Urinary Bladder: A Series of 22 Cases in a Single Center.
    Zhai H; Ma X; Nie W; Li H; Peng C; Li X; Zhang Y; Zhang X
    Clin Genitourin Cancer; 2017 Oct; 15(5):e765-e771. PubMed ID: 28688872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.
    Martin SA; Sears DL; Sebo TJ; Lohse CM; Cheville JC
    Am J Surg Pathol; 2002 Mar; 26(3):292-300. PubMed ID: 11859200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraganglioma of the urinary bladder: a clinicopathologic spectrum of a series of 14 cases emphasizing diagnostic dilemmas.
    Menon S; Goyal P; Suryawanshi P; Tongaonkar H; Joshi A; Bakshi G; Desai S
    Indian J Pathol Microbiol; 2014; 57(1):19-23. PubMed ID: 24739826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological study of pheochromocytoma of the urinary bladder: immunohistochemical, flow cytometric and ultrastructural findings with review of the literature.
    Kato H; Suzuki M; Mukai M; Aizawa S
    Pathol Int; 1999 Dec; 49(12):1093-9. PubMed ID: 10632931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraganglioma of the urinary bladder.
    Nesi G; Vezzosi V; Amorosi A; Menghetti I; Selli C
    Urol Int; 1996; 56(4):250-3. PubMed ID: 8776825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens.
    Zhou M; Epstein JI; Young RH
    Am J Surg Pathol; 2004 Jan; 28(1):94-100. PubMed ID: 14707870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
    Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
    Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms.
    Iczkowski KA; Shanks JH; Gadaleanu V; Cheng L; Jones EC; Neumann R; Nascimento AG; Bostwick DG
    Mod Pathol; 2001 Oct; 14(10):1043-51. PubMed ID: 11598176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study.
    Leonardi E; Dalla Palma P; Reich A; Caffo O; Luciani L
    Anal Cell Pathol; 2000; 21(1):21-33. PubMed ID: 11254222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus.
    Goto K; Kodama T; Matsuno Y; Yokose T; Asamura H; Kamiya N; Shimosato Y
    Mod Pathol; 2001 Oct; 14(10):985-94. PubMed ID: 11598168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
    Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
    Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
    Wolf HK; Stöber C; Hohenfellner R; Leissner J
    Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of MiB1 and p53 expression in human bladder tumors and their correlation with cancer progression.
    Pfister C; Buzelin F; Casse C; Bochereau G; Buzelin JM; Bouchot O
    Eur Urol; 1998; 33(3):278-84. PubMed ID: 9555552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion?
    Cheng L; Cheville JC; Sebo TJ; Eble JN; Bostwick DG
    Cancer; 2000 Feb; 88(4):853-61. PubMed ID: 10679655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional paragangliomas of the urinary bladder: a report of 9 cases.
    Deng JH; Li HZ; Zhang YS; Liu GH
    Chin J Cancer; 2010 Aug; 29(8):729-34. PubMed ID: 20663319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of malignant paraganglioma of urinary bladder.
    Shah VB; Bhandare AT
    Indian J Pathol Microbiol; 2015; 58(2):235-7. PubMed ID: 25885144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine carcinoma of the urinary bladder. 15-year retrospective analysis.
    Perán Teruel M; Giménez Bachs JM; Martínez Ruiz J; Fernández Anguita PJ; Nuñez Sarrión MA; Pastor Guzmán JM; Salinas Sánchez AS; Lorenzo Romero JG; Donate Moreno MJ; Atienzar Tobarra M; Virseda Rodríguez JA
    Arch Esp Urol; 2012 Mar; 65(2):237-43. PubMed ID: 22414452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary gland malignant myoepithelioma: a clinicopathologic and immunohistochemical study of ten cases.
    Nagao T; Sugano I; Ishida Y; Tajima Y; Matsuzaki O; Konno A; Kondo Y; Nagao K
    Cancer; 1998 Oct; 83(7):1292-9. PubMed ID: 9762928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.